Presentation Information
[Pe-005-4]Plasma NfL/GFAP index differentiates early Parkinson disease from elderly, MCI and Alzheimer disease
Akira Yokote1, Ken-ichiro Yamashita1,2, Tomohiro Imamura2,3, Atsushi Ohno4, Guzailiayi Maimaitijiang2, Yuki Yanagihara1,2, Keiko Haro1,2, Ayako Sakoda1,2, Yuri Nakamura1,2,3, Tomo Iura5, Yasuhiro Maeda5, Mari Shinoda5, Kaoru Yagita5, Nobutaka Sakae6, Naokazu Sasagasako6, Motohiro Yukitake7, Yasuhiko Baba8, Masakazu Hashimoto4, Noriko Isobe5, Jun-ichi Kira1,2,3,4 (1.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Japan, 2.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Japan, 3.Department of Pharmaceutical Sciences, School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 4.Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Japan, 5.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 6.Department of Neurology, National Hospital Organization, Omuta Hospital, Japan, 7.Department of Neurology, Kouhoukai Takagi Hospital, International University of Health and Welfare, Japan, 8.Department of Neurology, Faculty of Medicine, Fukuoka University, Japan)